Form D · Biotechnology
Duke Street Bio Ltd
London, X0 · CIK 0001823388
Offering snapshot reported Jun 11, 2026 · SEC filing
- Reported sold
- $4.14M Offering amount: $4.14M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 15, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2026 | Initial | $4,136,978 | No comparison | 2 | SEC filing |
| Jan 17, 2024 | Initial | $2,528,201 | No comparison | 1 | SEC filing |
| May 25, 2022 | Initial | $2,440,238 | No comparison | 1 | SEC filing |
| Jun 7, 2021 | Initial | $141,650 | No comparison | Not reported | SEC filing |
| Sep 9, 2020 | Initial | $26,595 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-587045
The offering amount was GBP3,100,021.00 The exchange rate used was 1GBP = USD1.3345.
Source: Form D, filed Jun 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donnie Christian | Director |
| Phillip Cowley | Director |
| Harvey Mc Grath | Director |
| Barry Mc Guinness | Executive |
| Peter Trill | Director |
| Robert Williams | Director |
| Alan Wise | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Duke Street
London, X0, W1U 3EH
London, X0, W1U 3EH